-
-
-
-
-
-
-
Analysts consider potential Qiagen deal amid reported strategic review
-
-
-
-
-
-
-
QIAGEN to acquire Parse Biosciences for $225 million
-
-
-
-
-
-
-
FBI approves QIAGEN’s NGS-based ForenSeq MainstAY workflow for the U.S. National DNA Index System (NDIS)
-
-
-
-
-
-
-
QIAGEN announces preliminary Q2 2021 results exceeding outlook, updates full-year 2021 outlook for declining COVID-19 test trends and plans new $100 million share repurchase program
-
-
-
-
-
-
-
QIAGEN to Continue Successful Growth Strategy Focused on Execution and Greater Value Creation After Voluntary Public Takeover Offer Falls Short
-
-
-
-
-
-
-
Qiagen (QGEN) Announces Shareholder Approve All Agenda Items Related to Thermo Fisher (TMO) Deal
-
-
-
-
-
-
-
Spok Appoints Christine Cournoyer to Board of Directors
-
1,157,743 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

